cancer

Check-Cap Shares Double Following FDA Approval of C-Scan Device

Check-Cap Shares Double Following FDA Approval of C-Scan Device

Shares of Check-Cap LTD (NASDAQ: CHEK) more than doubled this morning following the U.S. Food and Drug Administration's (FDA) approval of the Company’s C-Scan Device. The Pharmaceutical Company, based in Isfiya, Israel, dedicates its resea..

Lilly Shares Drop As Cancer Therapy Lartruvo Fails Study

Lilly Shares Drop As Cancer Therapy Lartruvo Fails Study

Eli Lilly & Co. (NYSE: LLY) said on Friday its cancer treatment Lartruvo, approved on an accelerated basis in 2016, failed to improve patient survival in a long-term study and will no longer be prescribed, driving shares down 3%.The Company said..